<?xml version="1.0" encoding="utf-8"?> <feed xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom"> <title type="text">InCrowd, Inc</title> <subtitle type="text">Contains the last 20 releases</subtitle> <id>uuid:102356e7-63ad-4922-973d-a792f8b7e881;id=32670</id> <rights type="text">Copyright 2020, InCrowd, Inc</rights> <updated>2020-03-26T11:00:00Z</updated> <author> <name>newsdesk@globenewswire.com (NewsDesk)</name> <uri>http://www.globenewswire.com/LegacyRss?Length=4</uri> <email>newsdesk@globenewswire.com</email> </author> <link rel="alternate" href="https://www.globenewswire.com/atomfeed/organization/LBw2dkqvXkl26U-DpPsCtw==" /> <link rel="self" href="https://www.globenewswire.com/atomfeed/organization/LBw2dkqvXkl26U-DpPsCtw==" /> <entry> <id>https://www.globenewswire.com/news-release/2020/03/26/2006860/0/en/US-Physicians-Aren-t-Being-Heard-on-COVID-19-But-They-Want-A-Voice-Even-More-So-Today-According-to-New-Data-by-InCrowd.html</id> <title type="text">US Physicians Aren’t Being Heard on COVID-19, But They Want A Voice Even More So Today, According to New Data by InCrowd</title> <published>2020-03-26T11:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/03/26/2006860/0/en/US-Physicians-Aren-t-Being-Heard-on-COVID-19-But-They-Want-A-Voice-Even-More-So-Today-According-to-New-Data-by-InCrowd.html" /> <content type="html"><![CDATA[While test kit availability has more than tripled since February, InCrowd’s Wave 3 COVID-19 data reports only 13% of respondents believe they have the necessary protective equipment needed to stay healthy <pre>While test kit availability has more than tripled since February, InCrowd’s Wave 3 COVID-19 data reports only 13% of respondents believe they have the necessary protective equipment needed to stay healthy</pre>]]></content> <dc:identifier>2006860</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Thu, 26 Mar 2020 11:00 GMT</dc:modified> <dc:subject>Calendar of Events</dc:subject> <dc:subject>Company Announcement</dc:subject> <dc:keyword>COVID-19</dc:keyword> <dc:keyword>Coronavirus</dc:keyword> <dc:keyword>pandemic</dc:keyword> <dc:keyword>public health</dc:keyword> <dc:keyword>healthcare</dc:keyword> <dc:keyword>PPE</dc:keyword> <dc:keyword>social distancing</dc:keyword> <dc:keyword>virus</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/03/10/1997946/0/en/InCrowd-Appoints-Global-Data-and-Research-Technology-Leader-Joseph-Baldini-as-Chief-Technology-Officer.html</id> <title type="text">InCrowd Appoints Global Data and Research Technology Leader Joseph Baldini as Chief Technology Officer</title> <published>2020-03-10T12:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/03/10/1997946/0/en/InCrowd-Appoints-Global-Data-and-Research-Technology-Leader-Joseph-Baldini-as-Chief-Technology-Officer.html" /> <content type="html"><![CDATA[Further accelerating the expansion and innovation of InCrowd’s insights platform for high-quality, focused market insights for the life sciences <pre>Further accelerating the expansion and innovation of InCrowd’s insights platform for high-quality, focused market insights for the life sciences</pre>]]></content> <dc:identifier>1997946</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Tue, 10 Mar 2020 12:00 GMT</dc:modified> <dc:subject>Directors and Officers</dc:subject> <dc:keyword>market research</dc:keyword> <dc:keyword>market insights</dc:keyword> <dc:keyword>marketing</dc:keyword> <dc:keyword>life sciences</dc:keyword> <dc:keyword>technology</dc:keyword> <dc:keyword>mobile technology</dc:keyword> <dc:keyword>R&D</dc:keyword> <dc:keyword>data</dc:keyword> <dc:keyword>analytics</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/28/1992825/0/en/Only-16-of-US-Physicians-Believe-the-US-Government-is-Taking-Strong-Precautions-to-Prevent-the-Spread-of-the-Coronavirus-According-to-Wave-2-of-InCrowd-s-COVID-19-Tracking-Report.html</id> <title type="text">Only 16% of US Physicians Believe the US Government is Taking Strong Precautions to Prevent the Spread of the Coronavirus, According to Wave 2 of InCrowd’s COVID-19 Tracking Report</title> <published>2020-02-28T16:22:48Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/28/1992825/0/en/Only-16-of-US-Physicians-Believe-the-US-Government-is-Taking-Strong-Precautions-to-Prevent-the-Spread-of-the-Coronavirus-According-to-Wave-2-of-InCrowd-s-COVID-19-Tracking-Report.html" /> <content type="html"><![CDATA[Just 14% of respondents feel very prepared to treat a patient with the virus, down from 25% in Wave 1 <pre>Just 14% of respondents feel very prepared to treat a patient with the virus, down from 25% in Wave 1</pre>]]></content> <dc:identifier>1992825</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Fri, 28 Feb 2020 16:22 GMT</dc:modified> <dc:subject>Health</dc:subject> <dc:subject>Research Analysis and Reports</dc:subject> <dc:keyword>Coronavirus</dc:keyword> <dc:keyword>COVID-19</dc:keyword> <dc:keyword>pandemic</dc:keyword> <dc:keyword>public health</dc:keyword> <dc:keyword>virus</dc:keyword> <dc:keyword>flu</dc:keyword> <dc:keyword>influenza</dc:keyword> <dc:keyword>healthcare</dc:keyword> <dc:keyword>infectious disease</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/27/1992082/0/en/How-Best-to-Fix-the-US-Healthcare-System-For-Physicians-It-Starts-with-Affordability-and-Access-Says-InCrowd-Data.html</id> <title type="text">How Best to Fix the US Healthcare System? For Physicians, It Starts with Affordability and Access, Says InCrowd Data</title> <published>2020-02-27T16:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/27/1992082/0/en/How-Best-to-Fix-the-US-Healthcare-System-For-Physicians-It-Starts-with-Affordability-and-Access-Says-InCrowd-Data.html" /> <content type="html"><![CDATA[Concerns for affordable healthcare and access escalate, some significantly; 80% believe ACA will be defunded though 74% say it will remain in place in 2020 <pre>Concerns for affordable healthcare and access escalate, some significantly; 80% believe ACA will be defunded though 74% say it will remain in place in 2020</pre>]]></content> <dc:identifier>1992082</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Thu, 27 Feb 2020 16:00 GMT</dc:modified> <dc:subject>Health</dc:subject> <dc:keyword>healthcare</dc:keyword> <dc:keyword>pharma</dc:keyword> <dc:keyword>Affordable Care Act</dc:keyword> <dc:keyword>ACA</dc:keyword> <dc:keyword>drug pricing</dc:keyword> <dc:keyword>universal healthcare</dc:keyword> <dc:keyword>physicians</dc:keyword> <dc:keyword>pharmaceutical industry</dc:keyword> <dc:keyword>healthcare reform</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/02/13/1984512/0/en/US-Physicians-Aren-t-Confident-About-US-Coronavirus-Preparedness-According-to-InCrowd-Data.html</id> <title type="text">US Physicians Aren’t Confident About US Coronavirus Preparedness, According to InCrowd Data</title> <published>2020-02-13T13:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/02/13/1984512/0/en/US-Physicians-Aren-t-Confident-About-US-Coronavirus-Preparedness-According-to-InCrowd-Data.html" /> <content type="html"><![CDATA[While 65% say they don’t have access to a COVID-19 test kit, only 9% are very concerned; verbatim remarks citing media hype, emphasize the greater concern is flu <pre>While 65% say they don’t have access to a COVID-19 test kit, only 9% are very concerned; verbatim remarks citing media hype, emphasize the greater concern is flu</pre>]]></content> <dc:identifier>1984512</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Thu, 13 Feb 2020 14:56 GMT</dc:modified> <dc:subject>Research Analysis and Reports</dc:subject> <dc:keyword>Coronavirus</dc:keyword> <dc:keyword>2019nCOV</dc:keyword> <dc:keyword>COVID-19</dc:keyword> <dc:keyword>pandemic</dc:keyword> <dc:keyword>Wuhan</dc:keyword> <dc:keyword>infectious disease</dc:keyword> <dc:keyword>influenza</dc:keyword> <dc:keyword>flu</dc:keyword> <dc:keyword>virus</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2020/01/30/1977609/0/en/2019-Brings-InCrowd-Record-Growth-New-Leadership-and-Investment-Partner-SARORAS-Capital.html</id> <title type="text">2019 Brings InCrowd Record Growth, New Leadership and Investment Partner SARORAS Capital</title> <published>2020-01-30T14:30:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2020/01/30/1977609/0/en/2019-Brings-InCrowd-Record-Growth-New-Leadership-and-Investment-Partner-SARORAS-Capital.html" /> <content type="html"><![CDATA[With more than 100 new life sciences brands and logos demanding high-quality and real-time insights <pre>With more than 100 new life sciences brands and logos demanding high-quality and real-time insights</pre>]]></content> <dc:identifier>1977609</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Thu, 30 Jan 2020 14:30 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:keyword>market research</dc:keyword> <dc:keyword>pharma</dc:keyword> <dc:keyword>market insights</dc:keyword> <dc:keyword>market intelligence</dc:keyword> <dc:keyword>biotech</dc:keyword> <dc:keyword>life sciences</dc:keyword> <dc:keyword>healthcare</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2018/08/21/1554632/0/en/InCrowd-Named-as-Finalist-for-Vendor-of-the-Year-from-PM360.html</id> <title type="text">InCrowd Named as Finalist for Vendor of the Year from PM360</title> <published>2018-08-21T13:50:54Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2018/08/21/1554632/0/en/InCrowd-Named-as-Finalist-for-Vendor-of-the-Year-from-PM360.html" /> <content type="html"><![CDATA[2018 Trailblazer Award Honors Vendors’ Commitment to The Life Sciences Through Innovation, Talent Development, Social Responsibility <pre>2018 Trailblazer Award Honors Vendors’ Commitment to The Life Sciences Through Innovation, Talent Development, Social Responsibility</pre>]]></content> <dc:identifier>1554632</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd, Inc</dc:contributor> <dc:modified>Tue, 21 Aug 2018 13:50 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:keyword>market research</dc:keyword> <dc:keyword>pharma</dc:keyword> <dc:keyword>biotech</dc:keyword> <dc:keyword>life sciences</dc:keyword> <dc:keyword>medical device</dc:keyword> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/04/25/990343/0/en/InCrowd-Captures-Market-Momentum-with-Three-New-Hires.html</id> <title type="text">InCrowd Captures Market Momentum with Three New Hires </title> <published>2017-04-25T12:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/04/25/990343/0/en/InCrowd-Captures-Market-Momentum-with-Three-New-Hires.html" /> <content type="html"><![CDATA[<p><em><p>With Its New Automated Solutions for Qualitative Research, Tracking Studies Driving Strong Q1 2017 Results, InCrowd's New Leaders Will Help Accelerate Company's Growth</p></em></p><p>BOSTON, MA--(Marketwired - Apr 25, 2017) - As the market research industry enters a renaissance where first-mover technology players are achieving superior growth, <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-05-25/h6qk5" title="InCrowd">InCrowd</a>, pioneer of real-time market intelligence to the life sciences and healthcare industries, named three veteran life science market research executives to help accelerate its ability to capture the heightened demand. </p>]]></content> <dc:identifier>990343</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/03/31/990341/0/en/A-Shot-of-Whiskey-a-Day-Keeps-the-Doctor-Away-and-That-s-No-April-Foolin-Says-InCrowd-Microsurvey.html</id> <title type="text">A Shot of Whiskey a Day Keeps the Doctor Away, and That's No April Foolin', Says InCrowd Microsurvey </title> <published>2017-03-31T11:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/03/31/990341/0/en/A-Shot-of-Whiskey-a-Day-Keeps-the-Doctor-Away-and-That-s-No-April-Foolin-Says-InCrowd-Microsurvey.html" /> <content type="html"><![CDATA[<p><em><p>From pigs causing anemia to a single insulin shot curing diabetes, US clinicians report the medical myths told to them by patients; the stranger side of patient care underscores the need for education and communication</p></em></p><p>BOSTON, MA--(Marketwired - Mar 31, 2017) - Medical misconceptions are rampant among the US patient population, and they underscore the need for continued patient education, according to a new microsurvey from <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-05-25/h6qk5" title="InCrowd">InCrowd</a>, provider of real-time market intelligence to the life sciences and healthcare industries.</p>]]></content> <dc:identifier>990341</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/03/21/990338/0/en/InCrowd-s-Janet-Kosloff-Named-a-Boston-SmartCEO-2017-Future-50-Award-Winner.html</id> <title type="text">InCrowd's Janet Kosloff Named a Boston SmartCEO 2017 Future 50 Award Winner </title> <published>2017-03-21T13:30:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/03/21/990338/0/en/InCrowd-s-Janet-Kosloff-Named-a-Boston-SmartCEO-2017-Future-50-Award-Winner.html" /> <content type="html"><![CDATA[<p><em><p>Among 60 Greater Boston companies to be recognized for fast growth, made possible by InCrowd's real-time market intelligence platform</p></em></p><p>BOSTON, MA--(Marketwired - Mar 21, 2017) - <strong> </strong><a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-05-25/h6qk5" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to the life sciences and healthcare firms, announced that its CEO and co-founder Janet Kosloff was named a Boston SmartCEO 2017 Future 50 Award winner by <em>SmartCEO</em> magazine. The program recognizes the region's 50 fastest-growing mid-sized companies and 10 small emerging growth companies, based on a combined three-year average of revenue and employee growth.</p>]]></content> <dc:identifier>990338</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/02/22/990334/0/en/InCrowd-Debuts-MicroQual-First-Qualitative-Micro-Research-Solution-for-Life-Sciences-Healthcare.html</id> <title type="text">InCrowd Debuts MicroQual, First Qualitative Micro Research Solution for Life Sciences & Healthcare </title> <published>2017-02-22T12:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/02/22/990334/0/en/InCrowd-Debuts-MicroQual-First-Qualitative-Micro-Research-Solution-for-Life-Sciences-Healthcare.html" /> <content type="html"><![CDATA[<p><em><p>By Allowing Completion of Healthcare Stakeholder Interviews in a Fraction of the Time, MicroQual Delivers Richer, More Comprehensive Market Insights, Sourced with Validated Experts</p></em></p><p>BOSTON, MA--(Marketwired - Feb 22, 2017) - <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-05-25/h6qk5" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to the life sciences and healthcare firms, introduces MicroQual, a qualitative research solution that applies the principles of micro research -- brevity and iteration -- to the qualitative market research process for healthcare. In early use by brand-name medical product providers, MicroQual reduced the typical 8- to 12-week process of securing and conducting qualitative interviews down to just one to two weeks -- enabling greater efficiency, flexibility, and a richer, more complete set of market insights that are essential to speeding vital treatments to market. </p>]]></content> <dc:identifier>990334</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2017/01/03/990331/0/en/For-Doctors-the-Trump-Effect-Is-Strong-Pessimism-on-Healthcare-Costs-Access-Quality-while-Believing-Some-Reforms-Remain-Says-Data-from-InCrowd.html</id> <title type="text">For Doctors, the "Trump Effect" Is Strong Pessimism on Healthcare Costs, Access & Quality, while Believing Some Reforms Remain, Says Data from InCrowd </title> <published>2017-01-03T16:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2017/01/03/990331/0/en/For-Doctors-the-Trump-Effect-Is-Strong-Pessimism-on-Healthcare-Costs-Access-Quality-while-Believing-Some-Reforms-Remain-Says-Data-from-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>Annual Microsurvey Shows More Pessimism that Drug Costs Can be Lowered; New Administration Seen as Likely to Retain Preexisting Conditions, Under Age 26 Coverage</p></em></p><p>BOSTON, MA--(Marketwired - Jan 3, 2017) - As a new President-Elect takes office with plans to dismantle much of the existing Affordable Care Act (ACA), US physicians are strongly pessimistic that key reform goals of improving healthcare quality, costs, and access will be achieved under the new administration, and they are increasingly pessimistic on lowering prescription drug costs. Yet 70% believe key ACA reforms will stay intact, specifically its insurance coverage for preexisting conditions and children up to age 26 being allowed to remain on their parents' insurance plans.</p>]]></content> <dc:identifier>990331</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/11/16/990326/0/en/More-Doctors-Say-Yes-to-Biosimilars-But-With-Increased-Caution-Than-6-Months-Ago-Says-New-Data-from-InCrowd.html</id> <title type="text">More Doctors Say Yes to Biosimilars, But With Increased Caution Than 6 Months Ago, Says New Data from InCrowd </title> <published>2016-11-16T14:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/11/16/990326/0/en/More-Doctors-Say-Yes-to-Biosimilars-But-With-Increased-Caution-Than-6-Months-Ago-Says-New-Data-from-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>While 84% Anticipate Prescribing Biosimilars in Next 3 Years -- up from 70% 6 Months Earlier -- Those Accepting Pharmacy-Level Substitution Drop From 28% to 17%</p></em></p><p>BOSTON, MA--(Marketwired - Nov 16, 2016) - As the FDA approves more biosimilars -- lower cost, similar yet not identical versions of already approved biologic drugs -- a notably larger percentage of US physicians say they intend to prescribe them in the coming three years. However, fewer would allow pharmacy-level substation of these drugs for their patients than just six months ago, and they are weighting more factors into their choice of potentially prescribing biosimilars at all. </p>]]></content> <dc:identifier>990326</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/11/10/990322/0/en/Citing-Themselves-as-a-Top-Factor-in-Prescribed-Opioid-Abuse-73-of-US-Physicians-Want-More-Alternative-Therapies-and-Less-Meds-Says-New-Data-from-InCrowd.html</id> <title type="text">Citing Themselves as a Top Factor in Prescribed Opioid Abuse, 73% of US Physicians Want More Alternative Therapies and Less Meds, Says New Data from InCrowd </title> <published>2016-11-10T13:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/11/10/990322/0/en/Citing-Themselves-as-a-Top-Factor-in-Prescribed-Opioid-Abuse-73-of-US-Physicians-Want-More-Alternative-Therapies-and-Less-Meds-Says-New-Data-from-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>"Doctors are Caught in the Middle"; A Cry for Systemic Change Including Patients, Payers and Providers</p></em></p><p>BOSTON, MA--(Marketwired - Nov 10, 2016) - US physicians who prescribe opioid pain medications are owning their role in today's opioid abuse while citing structural problems that feed the issue, and calling for more alternative therapies integrated with medication. The data are from the latest public health perception analysis created by <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-05-25/h6qk5" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to the life sciences and healthcare firms. </p>]]></content> <dc:identifier>990322</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/11/02/990319/0/en/US-Nurses-Vote-No-Confidence-on-Trump-and-Clinton-s-Ability-to-Improve-Healthcare-According-to-New-Data-From-InCrowd.html</id> <title type="text">US Nurses Vote No-Confidence on Trump and Clinton's Ability to Improve Healthcare, According to New Data From InCrowd </title> <published>2016-11-02T17:10:22Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/11/02/990319/0/en/US-Nurses-Vote-No-Confidence-on-Trump-and-Clinton-s-Ability-to-Improve-Healthcare-According-to-New-Data-From-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>63% Not At All Confident that Either Major Party Candidate Will Improve Current System; 39% Say Neither Is Addressing Healthcare Concerns Important to Them</p></em></p><p>BOSTON, MA--(Marketwired - Nov 2, 2016) - US nurses are profoundly dissatisfied with both major political party candidates for President when it comes to their ability to be successful in improving the current healthcare system, according to new data from <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-06-15/jfz81" title="InCrowd">InCrowd</a>, a real-time market insights technology firm.</p>]]></content> <dc:identifier>990319</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/10/28/990315/0/en/Sexual-Assault-Dialogues-Are-on-the-Rise-with-US-Clinicians-And-Despite-Lags-in-Patient-Awareness-They-See-Silver-Lining-in-Current-Discussions-Says-InCrowd-Data.html</id> <title type="text">Sexual Assault Dialogues Are on the Rise with US Clinicians, And Despite Lags in Patient Awareness, They See Silver Lining in Current Discussions, Says InCrowd Data </title> <published>2016-10-28T13:15:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/10/28/990315/0/en/Sexual-Assault-Dialogues-Are-on-the-Rise-with-US-Clinicians-And-Despite-Lags-in-Patient-Awareness-They-See-Silver-Lining-in-Current-Discussions-Says-InCrowd-Data.html" /> <content type="html"><![CDATA[<p><em><p>35% of Psychologists and Psychiatrists Say More Patients Discuss Sexual Assault With Them, While 55% Predict More Open Dialogues In Next 5 Years; Media Coverage the Largest Trigger</p></em></p><p>BOSTON, MA--(Marketwired - Oct 28, 2016) - As the topic of sexual assault gets continued examination via the US Presidential election, new data about US psychiatrists and psychologists' discussions on sexual assault with their patients suggest that these clinicians believe the nation has made strides in coming to terms with the topic in the past 5 years, and that such greater awareness may be a silver lining to recent political discourse.</p>]]></content> <dc:identifier>990315</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/04/26/990311/0/en/20-of-At-Risk-Women-Remain-Unaware-of-the-Zika-Virus-According-to-New-Data-From-InCrowd.html</id> <title type="text">20% of At-Risk Women Remain Unaware of the Zika Virus, According to New Data From InCrowd </title> <published>2016-04-26T12:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/04/26/990311/0/en/20-of-At-Risk-Women-Remain-Unaware-of-the-Zika-Virus-According-to-New-Data-From-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>77% of Physicians Think US Government Is not Doing Enough to Warn About Disease</p></em></p><p>BOSTON, MA--(Marketwired - Apr 26, 2016) - Despite the onset of spring and the reemergence of mosquitos, 20% of pregnant or would-be pregnant women polled in the US in April still have not heard news regarding the Zika virus -- a figure that has persisted since an initial poll in February. Data are from a new automated tracking survey gauging sentiments from OBGYNs and their patients, performed by <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-04-22/f3lfc" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to life sciences and healthcare firms.</p>]]></content> <dc:identifier>990311</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/04/25/990308/0/en/InCrowd-Named-a-2016-Cool-Vendor-in-Life-Sciences-by-Gartner.html</id> <title type="text">InCrowd Named a 2016 Cool Vendor in Life Sciences by Gartner </title> <published>2016-04-25T15:43:11Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/04/25/990308/0/en/InCrowd-Named-a-2016-Cool-Vendor-in-Life-Sciences-by-Gartner.html" /> <content type="html"><![CDATA[<p><em><p>Among the Life Science Vendors Cited as Innovative, Impactful, and Intriguing; Timely Life Science Market Insights via Mobile, Web, Cloud-Based Technology</p></em></p><p>BOSTON, MA--(Marketwired - Apr 25, 2016) - <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-04-25/f4st1" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to healthcare and life sciences firms, today announced that it has been included in the "Cool Vendors in Life Sciences, 2016" report just published by Gartner, Inc. </p>]]></content> <dc:identifier>990308</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/03/30/990304/0/en/In-Honor-of-National-Doctors-Day-InCrowd-Delivers-Its-One-Millionth-Answer-From-Its-Clinical-Crowd-to-the-Life-Sciences-Industry.html</id> <title type="text">In Honor of National Doctors Day, InCrowd Delivers Its One-Millionth Answer From Its Clinical "Crowd" to the Life Sciences Industry </title> <published>2016-03-30T13:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/03/30/990304/0/en/In-Honor-of-National-Doctors-Day-InCrowd-Delivers-Its-One-Millionth-Answer-From-Its-Clinical-Crowd-to-the-Life-Sciences-Industry.html" /> <content type="html"><![CDATA[<p><em><p>Using Automation to Deliver Vital Insights Faster, Without the Friction of Traditional Market Research</p></em></p><p>BOSTON, MA--(Marketwired - Mar 30, 2016) - As the healthcare industry celebrates National Doctors Day today, <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-03-29/c7lc9" title="InCrowd">InCrowd</a>, a provider of real-time market intelligence to healthcare and life sciences firms, announced that it has just issued the one millionth answer from its 1.8 million member clinical "Crowd" of physicians, nurses, pharmacists, and managed care experts to companies who use InCrowd to obtain business insights. These physicians and clinicians contribute their insights as a service to the life sciences companies that work with InCrowd by answering companies' pressing business, regulatory, and product questions -- insights that represent a faster and more meaningful approach to market research.</p>]]></content> <dc:identifier>990304</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> <entry> <id>https://www.globenewswire.com/news-release/2016/03/03/990300/0/en/Nearly-Half-of-US-Physicians-Say-They-Will-Prescribe-More-Biosimilars-According-to-New-Data-From-InCrowd.html</id> <title type="text">Nearly Half of US Physicians Say They Will Prescribe More Biosimilars, According to New Data From InCrowd </title> <published>2016-03-03T13:00:00Z</published> <updated>2024-11-26T18:07:15Z</updated> <link rel="alternate" href="https://www.globenewswire.com/news-release/2016/03/03/990300/0/en/Nearly-Half-of-US-Physicians-Say-They-Will-Prescribe-More-Biosimilars-According-to-New-Data-From-InCrowd.html" /> <content type="html"><![CDATA[<p><em><p>Lower Patient Costs Remain a Key Driver Across Five Specialties With Significant Biologic Use; 17% Believe Biosimilars Will Become the Norm in the Next Three Years</p></em></p><p>BOSTON, MA--(Marketwired - Mar 3, 2016) - In a new MicroSyndicated survey from <a rel="nofollow" href="http://answers.incrowdnow.com/l/129151/2016-02-29/8kdkj" title="InCrowd">InCrowd</a>, targeted US biologics prescribers shared their perceptions regarding the onset of biosimilars -- lower cost, similar yet not identical versions of already FDA-approved biologic drugs. Data suggests that, efficacy and safety considerations notwithstanding, US physician respondents are poised to embrace biosimilars as a potentially important way to reduce patient drug costs. </p>]]></content> <dc:identifier>990300</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>InCrowd</dc:contributor> <dc:modified>Tue, 19 Sep 2017 02:24 GMT</dc:modified> </entry> </feed>